Read Paper Details

Johnson and Johnson told to pay Rs 74.5 lakh as compensation for faulty implants

  • 11/03/2019
  •  The Central Drugs Standards and Control Organisation (CDSCO) has asked the pharmaceutical major Johnson and Johnson (J&J) to cough up  Rs 74.5 lakh as compensation to the first Indian victim of the faulty hip implants manufactured by the multinational company.
  • Nearly 4,700 Indians received the faulty hip implants — produced by DePuy International Limited, a subsidiary of J&J — between 2004 and 2010.
  • The flawed ‘ASR XL Acetabular Hip System’ and ‘ASR Hip Resurfacing System’ were recalled from the Indian market in August 2010 after the product’s global recall, but hundreds of recipients of the flawed implants were left in the lurch.
  • The compensation is the first one to be awarded to more than 4,000 Indian patients, who either underwent the faulty hip implant and subsequent correction surgeries or have someone from the family who suffered the agony and pain.